Paul Knight
Stock Analyst at Keybanc
(2.43)
# 2,542
Out of 5,017 analysts
137
Total ratings
48.67%
Success rate
-1.26%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $6.50 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $130.93 | +68.03% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.30 | +61.29% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $10.95 | +55.25% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $122.15 | +10.52% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.42 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $58.66 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $331.00 | +38.97% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.28 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $261.77 | +24.15% | 11 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.21 | +149.22% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $88.29 | +64.23% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $167.51 | +150.73% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $95.07 | +141.93% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $26.80 | +23.13% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $23.08 | +55.98% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $202.46 | +53.12% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $145.24 | +51.47% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $524.80 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $23.85 | +55.14% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.19 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.96 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $136.62 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $29.81 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $13.40 | +198.51% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $167.03 | +79.61% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $198.17 | +26.15% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $119.42 | +269.28% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $114.13 | +106.78% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $68.37 | +44.80% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $10.70 | +414.02% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $34.80 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $67.73 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $93.86 | - | 5 | Oct 23, 2017 |
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $6.50
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $130.93
Upside: +68.03%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.30
Upside: +61.29%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $10.95
Upside: +55.25%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $122.15
Upside: +10.52%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.42
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $58.66
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $331.00
Upside: +38.97%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.28
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $261.77
Upside: +24.15%
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.21
Upside: +149.22%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $88.29
Upside: +64.23%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $167.51
Upside: +150.73%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $95.07
Upside: +141.93%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $26.80
Upside: +23.13%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $23.08
Upside: +55.98%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $202.46
Upside: +53.12%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $145.24
Upside: +51.47%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $524.80
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $23.85
Upside: +55.14%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.19
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.96
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $136.62
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $29.81
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $13.40
Upside: +198.51%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $167.03
Upside: +79.61%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $198.17
Upside: +26.15%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $119.42
Upside: +269.28%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $114.13
Upside: +106.78%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $68.37
Upside: +44.80%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $10.70
Upside: +414.02%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $34.80
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $67.73
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $93.86
Upside: -